CD24 is a marker for human breast carcinoma

Cancer Letters

Volumn 143, Issue 1, 1999, Pages 87-94

  Fogel, Mina ^a   Friederichs, Jan ^b   Zeller, Yvonka ^b   Husar, Monica ^a   Smirnov, Asia ^a   Roitman, Lena ^a   Altevogt, Peter ^b   Sthoeger, Zev M ^a  

^a KAPLAN HOSPITAL   (Israel)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breast carcinoma; CD24; Metastasis; P selectin

Indexed keywords

CD24 ANTIGEN; PADGEM PROTEIN; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; ENDOTHELIUM CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; STAINING; TISSUE DISTRIBUTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD24; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; MEMBRANE GLYCOPROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032813445     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00195-0     Document Type: Article

References (33)

1. List of CD molecules, prow@ncbi.nlm.nih.gov.
2. Pirruccello S.J., LeBien T.W. The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J. Immunol. 136:1985;3779-3784.
3. Fischer G.F., Majdic O., Gadd S., Knapp W. Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J. Immunol. 144:1990;638-641.
4. Kay R., Rosten P.M., Humphries R.K. A signal transducer modulating B cell activation responses, is a very short peptide with a glycosylphosphatidylinositol membrane anchor. J. Immunol. 147:1991;1412-1416.
5. Jackson D., Waibel R., Weber E., Bell J., Stahel R.A. CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas, Cancer Res. 53:1992;5264-5270.
6. Akashi T., Shirasawa T., Hirokawa K. Gene expression of CD24 core polypeptide molecule in normal rat tissues and human tumor cell lines. Virchows Arch. 425:1994;399-406.
7. Sammar M., Aigner S., Hubbe M., Schirrmacher V., Schachner M., Vestweber D., Altevogt P. Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int. Immunol. 6:1994;1027-1036.
8. Aigner S., Sthoeger Z., Fogel M., Weber E., Zarn J., Ruppert M., Zeller Y., Vestweber D., Stahel R.A., Sammar M., Altevogt P. CD24, a mucin type glycoprotein, is a ligand for P-selectin on human tumors, Blood. 89:1997;3385-3395.
9. Sako D., Chang X.L., Barone K.M., Vachino G., White H.M., Shaw G., Veldman G.M., Bean K.M., Ahern T.J., Furie B., Cumming D.A., Larsen G.R. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 75:1993;1179-1186.
10. Moore K.L., Patel K.D., Bruehl R.E., Fugang L., Johnson D.A., Lichtenstein H.S., Cummings R.D., Bainton D.F., McEver R.P. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J. Cell Biol. 128:1995;661-671.
11. Aigner S., Ramos C.L., Hafezi-Moghadam A., Laurence M.B., Friederichs J., Altevogt P., Ley K. mediates rolling of breast carcinoma cells on P-selectin. FASEB J. 12:1998;1241-1251.
12. Frierson H.F. Jr, Wolber R.A., Berean K.W., Franquemont D.W., Gaffey M.J., Boyd J.C., Wilbur D.C. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am. J. Clin. Pathol. 103:1995;195-198.
13. Ebeling O., Duczmal A., Aigner S., Geiger C., Schöllhammer S., Kemshead J.T., Möller P., Schwartz-Albiez R., Altevogt P. L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. Eur. J. Immunol. 26:1996;2508-2516.
14. Lang E., Kohl U., Schirrmacher V., Brossmer R., Altevogt P. Structural basis for altered soybean agglutinin lectin binding between a murine metastatic lymphoma and an adhesive low malignant variant. Exp. Cell. Res. 173:1987;232-243.
15. Williams L.A., Hock B.D., Hart D.N. Human T lymphocytes and hematopoietic cell lines express CD24-associated carbohydrate epitopes in the absence of CD24 mRNA or protein. Blood. 88:1996;3048-3055.
16. Perri R.T., Royston I., LeBien T.W., Kay N. Chronic lymphocytic leukemia progenitor cells carry the antigens T65. BA-1 and Ia, Blood. 61:1983;871-875.
17. Lavabre-Bertrand T., Duperray C., Brunef C., Poncelet P., Exbrayat C., Bourquard P., Lavabre-Bertrand C., Brochier J., Navarro M., Janossy G. Quantitation of CD24 and CD45 antigen in parallel allows a precise determination of B cell maturation stages: relevance for the study of B cell neoplasias. Leukemia. 8:1994;402-408.
18. Droz D., Rousseau-Merck M.F., Jaubert F., Diebold N., Nezelof C., Adafer E., Mouly H. Cell differentiation in Wilms' tumor (nephroblastoma): an immunohistochemical study. Human Pathol. 21:1990;563-564.
19. Huang L.R., Hsu H.C. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res. 55:1995;4717-4721.
20. Zarn J.A., Zimmermann S.M., Pass M.K., Waibel R., Stahel R.A. Association of CD24 with the kinase c-fgr in a small cell lung cancer cell line and with the kinase lyn in an erythroleukemia cell line. Biochem. Biophys. Res. Commun. 225:1996;384-391.
21. Zhou Q., Guo Y., Liu Y. Regulation of the stability of heat-stable antigen mRNA by interplay between two novel cis elements in the 3′-untranslated region. Mol. Cell. Biol. 18:1998;815-826.
22. Pass M., Quintini G., Zarn J., Zimmermann S.M., Sigrist J.A., Stahel R.A. The 5′-flanking region of human CD24 gene has cell-type-specific promoter activity in small-cell lung cancer. Int. J. Cancer. 78:1998;496-502.
23. Kufe D., Inghirami G., Abe M., Hayes D., Justi-Wheeler H., Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma. 3:1984;223-232.
24. McGuckin M.A., Walsh M.D., Hohn B.G., Ward B.G., Wright G. Prognostic significance of Muc 1 epithelial mucin expression in breast cancer. Um. Pathol. 26:1995;432-439.
25. Ahnen D.J., Nakane P.K., Brown W.R. Ultrastructural localization of carcinoembryonic antigen in normal intestine and colon cancer: abnormal distribution of CEA on the surface of colon cancer cells, Cancer. 49:1982;2077-2090.
26. Aigner S., Ruppert M., Hubbe M., Sammar M., Sthoeger Z., Butcher E.C., Vestweber D., Altevogt P. Heat-stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. Int. Immunol. 7:1995;1557-1565.
27. Norman K.E., Moore K.L., McEver R.P., Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand 1. Blood. 86:1995;4417-4421.
28. Aruffo A., Dietsch M.T., Wan H., Hellström K.E., Hellström I. Granule membrane protein 140 (gpm140) binds to carcinomas and carcinoma-derived cell lines. Proc. Natl. Acad. Sci. USA. 89:1992;2292-2296.
29. Mannori G., Crottet P., Cecconi O., Hanasaki K., Aruffo A., Nelson R.M., Varki A., Bevilacqua M.P. Differential colon cancer cell adhesion to E-. P-, and L-selectin: role of mucin type glycoproteins, Cancer Res. 55:1995;425-431.
30. Stone J.P., Wagner D.D. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J. Clin. Invest. 92:1993;804-813.
31. Kim Y.J., Borsig L., Varki N.M., Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc. Natl. Acad. Sci. USA. 95:1998;9325-9330.
32. Honn K.V., Tang D.G., Chen Y.Q. Platelets and cancer metastasis: more than an epiphenomenon. Semin. Thromb. Hemost. 18:1992;392-415.
33. McCarthy J.B., Skubitz A.P., Iida J., Mooradian D.L., Wilke M.S., Furcht L.T. Tumor cell adhesive mechanisms and their relationship to metastasis. Semin. Cancer Biol. 2:1991;155-167.